Robert J Benschop

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Venues

Dermatology and therapy

Journal of translational medicine

Science translational medicine

mAbs

Eli Lilly and Co

Utrecht University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eli Lilly and Co

United States

Sr. Director :: Immunology

Education History

Utrecht University

Netherlands

PHD :: Immunology

Publications

Angela J Okragly, Aya Ryuzoji, Isabella Wulur, Montanea Daniels, Robert D Van Horn, Chetan N Patel, Robert J Benschop
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. Dermatology and therapy (2023)
Jonathan T Sims, Josh Poorbaugh, Ching-Yun Chang, Timothy R Holzer, Lin Zhang, Sarah M Engle, Stephanie Beasley, Thompson N Doman, Lynn Naughton, Richard E Higgs, Nicole Kallewaard, Robert J Benschop
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab. Journal of translational medicine 20 (1) (2022)
Robert J Benschop, Jay L Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L Kallewaard, Peter Vaillancourt, Melissa Crisp, Thi Ngoc Vy Trinh, Joshua J Freitas, Stephanie Beasley, Montanea Daniels, Natalie Haustrup, Richard E Higgs, Ajay Nirula, Myron S Cohen, Mary Marovich
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination. Science translational medicine 14 (655) (2022)
Angela J Okragly, Katie Brannon Corwin, Marikka Elia, Dongmei He, Oliver Schroeder, Qing Zhang, Tatiyana Shiyanova, Stuart Bright, Sarah B Dicker, Lukasz Chlewicki, Stephanie M E Truhlar, Julian Davies, Chetan N Patel, Robert J Benschop
Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33. Journal of inflammation research 14 (2021)
Robert J Benschop, Chi-Kin Chow, Yu Tian, James Nelson, Barbra Barmettler, Shane Atwell, David Clawson, Qing Chai, Bryan E Jones, Jon Fitchett, Stacy Torgerson, Yan Ji, Holly Bina, Ningjie Hu, Mahmoud Ghanem, Joseph Manetta, Victor J Wroblewski, Jirong Lu, Barrett W Allan
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs 11 (6) (2019)

Robert J Benschop.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert J Benschop